STUDY OF PHASE ID'ACIDE ZOLEDRONIC ASSOCIATED WITH A STRONG DOSE Hypofractionated Radiotherapy in Bone Metastases Vertebral Prostate Adenocarcinoma.
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Adenocarcinoma; Bone metastases; Prostate cancer
- Focus Adverse reactions
- Acronyms GEMO
- 18 Apr 2016 Status changed from recruiting to completed.
- 18 Oct 2010 New trial record